The recent federal government shutdown, which began on October 1, has sent ripples through the healthcare sector, creating significant disruptions for both providers and patients reliant on Medicare services. This unexpected halt in government operations has led to immediate holds on Durable
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology and innovation within the industry. With a strong background in research and development, Ivan brings a unique perspective on the integration of artificial intelligence in healthcare.
In an era where telehealth services have become a lifeline for many seeking convenient medical solutions, a troubling trend has emerged in the marketing of weight-loss drugs, particularly compounded GLP-1 medications. A staggering 1,200 percent increase in questionable advertisements since just a
The healthcare sector in the United States is at a critical juncture as private equity (PE) firms tighten their grip on hospitals, igniting fierce debate over the consequences for patient care and raising serious concerns about the balance between profit and well-being. With over $1 trillion
Imagine a world where millions of lives are lost each year to preventable conditions like heart disease, cancer, and diabetes, yet the momentum to combat these killers slows to a troubling crawl, leaving health systems and economies grappling with the consequences. In 2019, non-communicable
Brazil is emerging as a formidable force in the global clinical research arena, thanks to the recent enactment of Law 14.784/14, a pivotal regulation designed to overhaul the nation’s approach to clinical trials. Spearheaded by ANVISA, Brazil’s health regulatory agency, this legislation targets
